2C-C

Canonical status: restricted_other. Conventional 2C-C is not an expressly named NPSV entry; its supported Austrian coverage is through the generic NPSV Annex II no. 2 phenethylamine class, with NPSV § 1(1)(2) treating Annex II-covered substances as NPS. The supported NPSG consequence is the § 4(1) conduct- and intent-specific offense for advantage-seeking production, import, export, transfer or supply intended for another person's or a third party's psychoactive use, punishable by up to two years' imprisonment. NPSG §§ 2 and 5 preserve the stated lawful-marketing and lawful-purpose exceptions. These sources do not support an unqualified claim that simple possession or personal use of 2C-C is categorically prohibited.

The prior uncontrolled/unscheduled implication is corrected. 2C-C is covered by Annex 1 List B no. 460's generic Phenethylamin-gruppen because its 4-chloro-2,5-dimethoxyphenethylamine structure has the specified phenethylamine core with ring alkoxy and halogen substituents. The conclusion is not based on the absence of a standalone 2C-C line; it incorporates the List B medical/scientific-use limitation and the authorization and prescription exceptions in the current Danish regulation and section 2 of the governing statute.

The legacy entry's substance and general conclusion are supported, but its non-canonical status label "Controlled" is normalized to canonicalStatus prohibited and the legal instrument is made precise. The official Gazette decision expressly identifies 2C-C at annex item 47 with its chemical names and states that the listed substances are made subject to Law No. 2313 under Article 19. The latest general official national report inspected, the 2025 Türkiye Uyuşturucu Raporu, describes Turkey's NPS early-warning process and reports that 1,078 NPS had been brought within Law 2313 through 31 July 2025, including 143 phenethylamine-group substances. The latest relevant official Gazette placement decision located, Decision No. 11418 published 13 June 2026, adds six other substances; its annex does not restate 2C-C and does not purport to repeal the 2013 entry. The current Adalet Ministry TCK text provides conduct-level controls: Article 188(1) covers unlicensed or unauthorized manufacture, import or export; Article 188(3) covers domestic sale, offering, giving, dispatch, transport, storage, purchase, acceptance or possession; and Article 191(1) covers buying, accepting, possessing or using for personal use. The published penalty ranges are quoted in the claims and relevantRules, but this dossier does not assert a specific sentence for a particular 2C-C case. It does not infer that the Article 188(4)(a) half-increase for amphetamine and derivatives applies merely because 2C-C is a phenethylamine and is listed in the annex. The schedule decision itself does not describe medical, research, licensing, quantity or other exceptions; any authorization or exception must be checked against operative Turkish legislation for the particular conduct. A bounded currentness gap remains: no official consolidated 2026 schedule reproducing every prior entry or later individual amendment to the 2013/4827 item was located. The exact-name listing is directly confirmed by the official Gazette, and the latest official NPS decision and 2025 national report confirm the continuing Law 2313 framework; no repeal is inferred from an entry's absence from a later additions list.

Supported replacement: 2C-C is expressly listed by the current Criminal Code Regulations as both a controlled drug and a border controlled drug. The Criminal Code Act therefore supplies federal conduct-specific routes for possession and import/export, subject to the statutory elements and fault rules; listing alone is not an unqualified prohibition of every act. The current June 2026 Poisons Standard places alkoxyphenylethylamines and substituted alkoxyphenylethylamines in Schedule 9, whose prohibited-substance description includes approved research and analytical, teaching or training exceptions and whose implementation may vary among States and Territories. Customs Schedule 4 item 5B lists the alkoxyphenylethylamine class, and regulation 5 conditionally prohibits importation of a covered drug absent the required licence, permission, presentation, timing and quantity compliance, subject to its approval and medical exceptions. No State or Territory law is inferred, and no blanket ban on all substituted phenethylamines or the entire 2C-X family is claimed.

2C-C is expressly listed by exact chemical identity in China's current non-medical narcotic and psychotropic catalog. The catalog distinguishes it from the separate item 3, 2C-C-NBOMe (CAS 1227608-02-7). The current catalog was issued on 2025-07-21 and took effect on publication, replacing the prior supplemental catalog; the exact 2C-C entry was already in the 2015 supplemental catalog, whose measure took effect on 2015-10-01. Under current Regulation Article 4, a non-medical listed substance may be used for experimental research only as provided by the Regulation and may not be produced, operated/sold, used, stored, or transported. The 2015 implementing measure expressly prohibits any unit or individual from producing, buying/selling, transporting, using, storing, or importing/exporting listed non-medical substances, while preserving regulated handling for research, testing standards/reference materials, and specified intermediates. The cited instruments state no personal-use quantity threshold or amount-based exception; this dossier does not infer one. The current catalog note includes possible salts, stereoisomers, and their salts unless otherwise provided. Regulation Article 82 provides, where a violation causes a controlled narcotic or psychotropic substance to enter an illicit channel and cause harm, criminal liability where constitutive, or otherwise a RMB 50,000–100,000 police fine plus confiscation; serious cases may add a 2–5-times-illegal-proceeds fine and cancellation of the relevant license.

2C-C is expressly named in Finland's current consumer-market-banned psychoactive-substance annex, with the chemical identity 2-(2,5-dimethoxy-4-chlorophenyl)ethanamine. No generic analogue rule is needed for this finding: the exact name is listed. The Narcotics Act definition expressly excludes medicinal substances and narcotics from this category, so the supported canonical status is restricted_other and this entry does not assert separate narcotic-schedule classification. Section 5(2) bans manufacture, import, storage, offering for sale and transfer; it does not itself state a blanket possession-or-use prohibition. The identified exceptions are the research and justified industrial routes with prior notification, plus the low-misuse-risk mixture/preparation exception in section 23b. Criminal Code chapter 44 section 5a provides a fine or up to one year's imprisonment for intentional or grossly negligent violations, unless a more severe offence applies.

The legacy Controlled wording is normalized to the canonical prohibited status and the source-backed legal location. The current consolidated ordinance text (displayed as updated 17 June 2025) places 2C-C by exact chemical name and synonym in First Schedule Part A, Section B, item 3ג. The ordinance definition of dangerous drug covers substances in the First Schedule, their salts, and preparations, compounds, mixtures or solutions; Part A item 3ג is not the Part B medicinal-possession category described by section 11. Section 7(a) prohibits possession or use except as authorized by the Ordinance, regulations or a Director's licence; section 7(c) provides a general maximum of 20 years' imprisonment or 25 times the statutory fine, and a personal-consumption-only maximum of three years or the ordinary statutory fine. Section 6 applies the same 20-year/25-times maximum to unauthorized growing, production, extraction, preparation or manufacture. Section 13 prohibits unauthorized export, import, facilitating export/import, trade, other dealing or supply, and section 19A provides the same 20-year/25-times maximum for violations of that trade/import sign. These are statutory maxima and do not imply that every case receives the maximum. The 2025 official Reshumot notice amended the First Schedule's chemical-group definition and inserted other named substances; the current consolidated text after that notice still contains item 3ג, with no repeal shown. The prior note's specific December 2008 date is not retained: the current consolidated entry does not state a Gregorian month, while the UNODC intergovernmental Israel record reports known first control in 2007 under Notice 5767-2007. The exact historical notice/date is therefore left bounded rather than inferred. The Ministry of Health's official ordinance page directs users to the linked external consolidated legal text and warns that law controls if page information conflicts; the classification and penalties here are based on the fetched consolidated ordinance and official government report.

The exact trivial name 2C-C is not printed as a separate named entry in the current Annex 2 text. The supported conclusion is structural: official NIH PubChem identifies 2C-C as 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine, while List I II.11(1) expressly covers derivatives of 2-(2,5-dimethoxyphenyl)ethanamine bearing benzene-ring substituents. List I is the prohibited category; § 5 bans ordinary cultivation, production, manufacture, import/export, distribution, advertising, transport, storage, transfer, acquisition, use and transit. The 0.02 g and 2 g thresholds classify small and large quantities and do not create a personal-use exception. The only identified authorization route is § 7 for specified medical/veterinary scientific research, physical/chemical property determination and training.